In Brief This Week: Life Technologies, FTC; Abbott; Saladax; PerkinElmer; Vermillion; More | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said late last week in a regulatory filing that it has received a second request from the US Federal Trade Commission for more information about its pending $13.6 billion sale to Thermo Fisher Scientific. The company said it is cooperating with FTC and continues to expect the acquisition to close in early 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.